X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1963) 1963
Publication (117) 117
Book Chapter (22) 22
Book Review (9) 9
Dissertation (8) 8
Book / eBook (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1338) 1338
female (1309) 1309
ovarian neoplasms - pathology (927) 927
adult (741) 741
index medicus (717) 717
middle aged (694) 694
obstetrics & gynecology (678) 678
oncology (657) 657
ovarian cancer (533) 533
aged (512) 512
cancer (512) 512
pathology (509) 509
carcinoma (419) 419
borderline tumors (414) 414
ovary (362) 362
neoplasm staging (358) 358
prognosis (353) 353
ovarian neoplasms - surgery (344) 344
tumors (342) 342
borderline (315) 315
retrospective studies (284) 284
surgery (281) 281
ovarian neoplasms - genetics (265) 265
adolescent (252) 252
aged, 80 and over (252) 252
immunohistochemistry (234) 234
borderline ovarian tumor (232) 232
diagnosis (219) 219
ovarian neoplasms - diagnosis (218) 218
recurrence (196) 196
young adult (195) 195
cystadenocarcinoma, serous - pathology (194) 194
women (183) 183
fertility (166) 166
management (157) 157
adenocarcinoma, mucinous - pathology (155) 155
survival (154) 154
borderline ovarian tumors (152) 152
borderline tumor (150) 150
expression (150) 150
epithelial tumors (145) 145
ovarian neoplasms - metabolism (145) 145
neoplasm invasiveness (139) 139
ovarian neoplasms - mortality (139) 139
diagnosis, differential (138) 138
mutation (130) 130
neoplasms (130) 130
obstetrics and gynecology (127) 127
pregnancy (127) 127
serous borderline tumors (122) 122
benign (121) 121
follow-up studies (118) 118
malignancy (118) 118
carcinomas (115) 115
risk factors (115) 115
analysis (113) 113
peritoneal implants (112) 112
laparoscopy (110) 110
treatment outcome (109) 109
ovarian neoplasms - therapy (105) 105
clinicopathological analysis (104) 104
research (104) 104
chemotherapy (103) 103
survival rate (103) 103
ovarian neoplasms - epidemiology (100) 100
borderline malignancy (99) 99
serous borderline tumor (99) 99
mucinous tumors (98) 98
behavior (96) 96
ovarian carcinoma (96) 96
carcinoma - pathology (90) 90
mutations (90) 90
serous tumors (90) 90
medicine & public health (89) 89
ovarian tumors (89) 89
ovarian neoplasms - classification (88) 88
neoplasms, glandular and epithelial - pathology (87) 87
care and treatment (85) 85
reproductive biology (84) 84
features (83) 83
follow-up (83) 83
low-grade (83) 83
neoplasm recurrence, local - pathology (83) 83
ovarian neoplasms (83) 83
conservative surgery (80) 80
cystadenoma, serous - pathology (79) 79
health aspects (79) 79
ovariectomy (79) 79
hematology, oncology and palliative medicine (77) 77
intestinal-type (77) 77
metastasis (77) 77
origin (77) 77
ovary - pathology (77) 77
endocrine system diseases (76) 76
ovarian neoplasms - diagnostic imaging (75) 75
endometriosis (74) 74
cystadenocarcinoma, serous - genetics (73) 73
radiology, nuclear medicine & medical imaging (73) 73
conservative treatment (72) 72
low malignant potential (72) 72
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1787) 1787
French (73) 73
Korean (52) 52
German (37) 37
Spanish (15) 15
Japanese (11) 11
Russian (8) 8
Turkish (8) 8
Portuguese (4) 4
Chinese (3) 3
Czech (3) 3
Polish (3) 3
Italian (2) 2
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Pathology, ISSN 0022-3417, 12/2013, Volume 231, Issue 4, pp. 449 - 456
BRAF and KRAS mutations in ovarian serous borderline tumours (OSBTs) and ovarian low‐grade serous carcinomas (LGSCs) have been previously described. However,... 
mutation | deep sequencing | ovarian low‐grade serous carcinoma | KRAS | BRAF | serous borderline tumour | COLD‐PCR | COLD-PCR | ovarian low-grade serous carcinoma | SURVIVAL | NEOPLASMS | IMPLANTS | PATHOLOGY | PATHOGENESIS | CANCER GENOMICS | ONCOLOGY | RAS MUTATIONS | PROTEIN MUTATIONS | EXPRESSION | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Prognosis | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | DNA Mutational Analysis - methods | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Adult | Female | Cell Death - drug effects | Tumor Cells, Cultured | High-Throughput Nucleotide Sequencing - methods | MAP Kinase Kinase Kinases - antagonists & inhibitors | Neoplasm Proteins - genetics | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Proto-Oncogene Proteins B-raf - genetics | Benzimidazoles - pharmacology | Neoplasm Recurrence, Local - genetics | Aged | Protein Kinase Inhibitors - pharmacology | DNA, Neoplasm - genetics | Mutation | Cystadenoma, Serous - genetics | Cystadenoma, Serous - pathology | Proteins | Relapse | Carcinoma | Gene mutations | Genomics | Analysis | Denaturation | Cancer | Diseases | KRAS mutation | Ovarian low-grade serous carcinoma | Serous borderline tumor | Deep sequencing | KRAS G12V | BRAF mutation | Full COLD-PCR
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 03/2004, Volume 100, Issue 5, pp. 1045 - 1052
Journal Article
Journal Article
Journal Article
REVISTA DE CHIMIE, ISSN 0034-7752, 11/2019, Volume 70, Issue 11, pp. 3957 - 3960
Abdominal-pelvic masses are an important part of the female pelvic pathology. They can belong either to the uterus, ovaries or the fallopian tubes. The main... 
CA 19-9 | ENGINEERING, CHEMICAL | mucinous ovarian tumour | borderline tumour | ovarian cancer | CA-125 | CA125 | CANCER | CHEMISTRY, MULTIDISCIPLINARY | inhibin
Journal Article